At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 9, 2026 at 20:00 ET
BridgeBio Pharma CEO Kumar Neil was granted a total of 144,883 shares in non-cash awards and sold 9,690 shares in an open-market transaction worth approximately $662,441. The sale represents a small fraction of the company's market cap and is likely part of a pre-arranged trading plan.
- CEO Kumar Neil received two non-cash stock awards totaling 144,883 shares with no economic value at grant.
- CEO sold 9,690 shares in an open-market transaction at $68.3634 per share, totaling $662,441.
- Total value of open-market sale is $662,441, representing approximately 0.0049% of BBIO's $13.6B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access